UBS Asset Management Americas Inc. increased its stake in shares of Stericycle Inc (NASDAQ:SRCL) by 8.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,608,752 shares of the business services provider’s stock after buying an additional 278,461 shares during the period. UBS Asset Management Americas Inc.’s holdings in Stericycle were worth $172,318,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its holdings in Stericycle by 1.6% during the second quarter. BlackRock Inc. now owns 7,587,862 shares of the business services provider’s stock worth $362,321,000 after buying an additional 117,311 shares in the last quarter. Iridian Asset Management LLC CT lifted its holdings in shares of Stericycle by 0.9% in the second quarter. Iridian Asset Management LLC CT now owns 3,126,210 shares of the business services provider’s stock valued at $149,277,000 after purchasing an additional 27,637 shares in the last quarter. FMR LLC lifted its holdings in shares of Stericycle by 31.8% in the first quarter. FMR LLC now owns 2,632,945 shares of the business services provider’s stock valued at $143,285,000 after purchasing an additional 635,344 shares in the last quarter. Ontario Teachers Pension Plan Board purchased a new stake in shares of Stericycle in the second quarter valued at about $75,114,000. Finally, Champlain Investment Partners LLC lifted its holdings in shares of Stericycle by 2.6% in the first quarter. Champlain Investment Partners LLC now owns 1,527,793 shares of the business services provider’s stock valued at $83,142,000 after purchasing an additional 38,750 shares in the last quarter.
Shares of NASDAQ SRCL traded down $0.97 on Tuesday, hitting $49.10. The company’s stock had a trading volume of 23,683 shares, compared to its average volume of 923,783. The stock has a 50 day moving average of $46.18 and a 200-day moving average of $48.80. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market capitalization of $4.59 billion, a price-to-earnings ratio of 11.03, a price-to-earnings-growth ratio of 2.43 and a beta of 1.21. Stericycle Inc has a 12-month low of $34.36 and a 12-month high of $61.78.
Several analysts have issued reports on the stock. Robert W. Baird raised shares of Stericycle from an “underperform” rating to a “neutral” rating and set a $44.00 price target on the stock in a report on Friday, August 2nd. Bank of America reaffirmed an “underperform” rating and issued a $44.00 price target (down previously from $46.00) on shares of Stericycle in a report on Wednesday, July 17th. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Thursday, September 12th. Finally, ValuEngine raised shares of Stericycle from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 6th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $51.80.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Featured Story: Put Option
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.